← MF leaderboard

Nippon India Nifty Pharma ETF

Nippon India Mutual Fund · Index & ETF · mandate: passive replication of the stated index · tracks: Nifty Pharma
AUM (all plans)
1,458 cr
TER direct / regular
0.21% / 0.00%
Tracks (from name)
Nifty Pharma
CAGR (full)
13.2%
Sharpe (full)
0.49
Sharpe (bull ≤Sep-24)
2.65
Sharpe (sideways Oct-24→)
0.13
Max drawdown
-18.1%
Months of data
61
Percentile ranks this fund within its peer pool; the leaderboard Score is the weighted average of its fiscal-year percentiles (equity: active-return-rank blended with IR-rank).

Equity curve

20212022202320242025202682136189Fund (NAV=100)Risk-free 6%/yrCategory median (Other ETFs)

Drawdown

202120222023202420252026-18-90Drawdown %

Fiscal-year record

FYReturnvs categorySharpemonths
FY22*-5.5%-13.5%-0.978
FY23-10.9%-11.2%-1.4412
FY2458.9%21.5%2.7012
FY2511.7%5.6%0.3512
FY265.7%6.8%0.0212
FY27*18.8%7.5%4.395
Active/Fund returns are TOTALS over the months covered — never annualized (FY27* is year-to-date; a * row covers only part of the year). %ile is the fund's percentile within its peer pool for that year.

Monthly returns (%)

JanFebMarAprMayJunJulAugSepOctNovDecYear
2021-0.4+0.8-4.0-1.5+4.1-1.3
2022-7.3-1.7+5.1-0.9-6.4-3.5+5.2-0.3+2.1+1.8-0.5-4.2-10.9
2023-1.9-4.7+2.3+4.9+0.5+8.6+9.3+0.8+2.2-4.8+10.6+3.6+34.4
2024+6.6+6.1-0.1-0.2-0.9+5.0+10.6+6.8+0.2-2.4-2.2+5.2+39.6
2025-8.4-7.4+6.7+3.0-1.5+2.9+3.6-4.2-1.6+3.4+3.7-1.2-2.5
2026-4.5+5.9-3.2+4.6+4.6+4.1+4.9-0.7+16.4

Quarterly average AUM & estimated net flows

202120222023202420252026527551,458AUM (quarter avg), ₹cr
-13262
Quarterly net flow estimate: AUM_q − AUM_(q−1)·(1+quarter return). AUM shown is the quarter AVERAGE (AMFI central disclosure). Positive = net inflows, ₹cr.
Source: AMFI's official all-scheme NAV history (portal report; official NAV history, net of TER by construction). Monthly returns are month-end NAV chains; stale prints (>7 days before month-end) drop out rather than carry. Benchmark series are the median of plain-vanilla direct-plan index funds tracking each index (TRI minus ~10-25bp/yr tracking drag — verified against true-TRI chains). Direct plans, growth option only. Sharpe uses rf 6%, arithmetic monthly convention. Independence: all figures are computed from mandatory public disclosures with a fixed methodology applied identically to every fund — no fund can pay for inclusion, exclusion, placement, or altered presentation, and any material commercial relationship will be disclosed on the affected pages. Nothing here is investment advice; past performance does not predict future returns. Generated 2026-08-25 05:37Z · data through Aug 2026 · leaderboard · PMS leaderboard
Feedback, inputs, or bug reports are appreciated — @vivekrmr on X · LinkedIn.